# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 16, "BMC Ophthalmol .", "", "<http://ctro/data#Publication_94880> <http://ctro/data#hasJournal> \"BMC Ophthalmol .\"."
1, PublicationYear, 17, 21, "2014", "", "<http://ctro/data#Publication_94880> <http://ctro/data#hasPublicationYear> \"2014\"."
2, Title, 85, 290, "Late - day intraocular pressure - lowering efficacy and tolerability of travoprost 0 . 004 % versus bimatoprost 0 . 01 % in patients with open - angle glaucoma or ocular hypertension : a randomized trial .", "", "<http://ctro/data#Publication_94880> <http://ctro/data#hasTitle> \"Late - day intraocular pressure - lowering efficacy and tolerability of travoprost 0 . 004 % versus bimatoprost 0 . 01 % in patients with open - angle glaucoma or ocular hypertension : a randomized trial .\"."
3, IOP, 96, 116, "intraocular pressure", "", 
4, Travoprost, 157, 167, "travoprost", "", 
6, DoseValue, 168, 175, "0 . 004", "", 
110, Percentage, 176, 177, "%", "", 
5, Bimatoprost, 185, 196, "bimatoprost", "", 
7, DoseValue, 197, 203, "0 . 01", "", 
111, Percentage, 204, 205, "%", "", 
8, OpenAngleGlaucoma, 223, 244, "open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OpenAngleGlaucoma>."
9, OcularHypertension, 248, 267, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
10, Randomized, 272, 282, "randomized", "", 
11, Author, 291, 301, "DuBiner HB", "", "<http://ctro/data#Publication_94880> <http://ctro/data#hasAuthor> \"DuBiner HB\"."
12, Author, 310, 321, "Hubatsch DA", "", "<http://ctro/data#Publication_94880> <http://ctro/data#hasAuthor> \"Hubatsch DA\"."
114, USA, 434, 437, "USA", "", "<http://ctro/data#Population_94909> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
13, IOP, 508, 528, "intraocular pressure", "", 
14, IOP, 531, 534, "IOP", "", 
104734, ProstaglandinAnalogs, 698, 711, "prostaglandin", "", 
23, ObjectiveDescription, 751, 997, "The present study compared the efficacy and safety of BAK - free travoprost 0 . 004 % ( TRAV ) and BAK 0 . 02 % - preserved bimatoprost 0 . 01 % ( BIM ) during late - day time points in patients with open - angle glaucoma or ocular hypertension .", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasObjectiveDescription> \"The present study compared the efficacy and safety of BAK - free travoprost 0 . 004 % ( TRAV ) and BAK 0 . 02 % - preserved bimatoprost 0 . 01 % ( BIM ) during late - day time points in patients with open - angle glaucoma or ocular hypertension .\"."
15, Travoprost, 805, 826, "BAK - free travoprost", "", "<http://ctro/data#Medication_94918> <http://ctro/data#hasDrug> <http://ctro/data#Travoprost>."
17, DoseValue, 827, 834, "0 . 004", "", "<http://ctro/data#Medication_94918> <http://ctro/data#hasDoseValue> \"0 . 004\"."
130, Percentage, 835, 836, "%", "", "<http://ctro/data#Medication_94918> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
19, Travoprost, 839, 843, "TRAV", "", 
104738, Bimatoprost, 850, 853, "BAK", "", 
126, DoseValue, 854, 860, "0 . 02", "", 
128, Percentage, 861, 862, "%", "", 
104738, Bimatoprost, 863, 886, "- preserved bimatoprost", "", "<http://ctro/data#Medication_94925> <http://ctro/data#hasDrug> <http://ctro/data#Bimatoprost>."
18, DoseValue, 887, 893, "0 . 01", "", "<http://ctro/data#Medication_94925> <http://ctro/data#hasDoseValue> \"0 . 01\"."
129, Percentage, 894, 895, "%", "", "<http://ctro/data#Medication_94925> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
20, Bimatoprost, 898, 901, "BIM", "", 
104743, Precondition, 937, 995, "patients with open - angle glaucoma or ocular hypertension", "", "<http://ctro/data#Population_94909> <http://ctro/data#hasPrecondition> \"patients with open - angle glaucoma or ocular hypertension\"."
21, OpenAngleGlaucoma, 951, 972, "open - angle glaucoma", "", 
22, OcularHypertension, 976, 995, "ocular hypertension", "", 
24, Duration, 1019, 1028, "12 - week", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasCTduration> \"12 - week\"."
25, CTDesign, 1031, 1038, "phase 4", "", "<http://ctro/data#CTDesign_94894> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTDesign>. <http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasCTDesign> <http://ctro/data#CTDesign_94894>."
26, Randomized, 1041, 1051, "randomized", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
27, Blind, 1054, 1075, "investigator - masked", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind>."
28, Crossover, 1078, 1087, "crossover", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasCTDesign> <http://ctro/data#Crossover>."
29, NumberPatientsCT, 1096, 1098, "84", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasNumberPatientsCT> \"84\"."
32, Precondition, 1099, 1135, "patients with IOP ≥ 24 and < 36 mmHg", "", "<http://ctro/data#Population_94909> <http://ctro/data#hasPrecondition> \"patients with IOP ≥ 24 and < 36 mmHg\"."
30, IOP, 1113, 1116, "IOP", "", 
31, mmHg, 1131, 1135, "mmHg", "", 
33, Randomized, 1141, 1151, "randomized", "", 
34, AllocationRatio, 1152, 1157, "1 : 1", "", "<http://ctro/data#AllocationRatio_94892> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio>. <http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_94892>."
35, Frequency, 1169, 1181, "once - daily", "", "<http://ctro/data#Intervention_94932> <http://ctro/data#hasFrequency> \"once - daily\". <http://ctro/data#Intervention_94938> <http://ctro/data#hasFrequency> \"once - daily\"."
36, Travoprost, 1182, 1186, "TRAV", "", 
37, Bimatoprost, 1190, 1193, "BIM", "", 
38, Duration, 1198, 1205, "6 weeks", "", 
39, Duration, 1232, 1240, "6 - week", "", 
40, Crossover, 1241, 1250, "crossover", "", 
41, IOP, 1260, 1263, "IOP", "", 
148, TimePoint, 1316, 1332, "4 , 6 , and 8 pm", "", 
147, TimePoint, 1320, 1332, "6 , and 8 pm", "", 
146, TimePoint, 1328, 1332, "8 pm", "", 
42, Travoprost, 1335, 1339, "TRAV", "", 
43, Bimatoprost, 1370, 1373, "BIM", "", 
44, Mean, 1445, 1449, "mean", "", 
45, IOP, 1450, 1453, "IOP", "", 
46, mmHg, 1466, 1470, "mmHg", "", 
155, NumPatientsLeftCT, 1535, 1538, "One", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasNumPatientsLeftCT> \"One\"."
104745, EndPointDescription, 1567, 1590, "allergic conjunctivitis", "", 
156, NumPatientsLeftCT, 1597, 1598, "2", "", 
47, FinalNumPatientsCT, 1642, 1644, "81", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasFinalNumberPatientsCT> \"81\"."
48, PerProtocol, 1675, 1689, "per - protocol", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#PerProtocol>."
49, Mean, 1703, 1707, "mean", "", 
50, AvgAge, 1719, 1725, "58 . 3", "", "<http://ctro/data#Population_94909> <http://ctro/data#hasAvgAge> \"58 . 3\"."
51, Travoprost, 1743, 1747, "TRAV", "", 
52, Bimatoprost, 1750, 1753, "BIM", "", 
161, FinalNumPatientsArm, 1760, 1762, "41", "", "<http://ctro/data#Arm_94944> <http://ctro/data#hasFinalNumPatientsArm> \"41\"."
166, Bimatoprost, 1765, 1768, "BIM", "", 
164, Travoprost, 1771, 1775, "TRAV", "", 
162, FinalNumPatientsArm, 1782, 1784, "40", "", "<http://ctro/data#Arm_94953> <http://ctro/data#hasFinalNumPatientsArm> \"40\"."
106372, TimePoint, 1795, 1802, "6 weeks", "", "<http://ctro/data#Outcome_94967> <http://ctro/data#hasTimePoint> \"6 weeks\". <http://ctro/data#Outcome_94994> <http://ctro/data#hasTimePoint> \"6 weeks\"."
56, Mean, 1805, 1809, "mean", "", "<http://ctro/data#Mean_94964> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_94962> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_94964>."
57, IOP, 1810, 1813, "IOP", "", "<http://ctro/data#IOP_94963> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_94962> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_94963>."
58, Travoprost, 1819, 1823, "TRAV", "", 
59, ResultMeasuredValue, 1826, 1832, "17 . 4", "", "<http://ctro/data#Outcome_94967> <http://ctro/data#hasResultMeasuredValue> \"17 . 4\"."
61, SdDevResValue, 1835, 1840, "2 . 7", "", "<http://ctro/data#Outcome_94967> <http://ctro/data#hasSdDevResValue> \"2 . 7\"."
63, mmHg, 1841, 1845, "mmHg", "", "<http://ctro/data#Endpoint_94962> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
65, Reduction, 1873, 1878, "6 . 0", "", "<http://ctro/data#Outcome_94967> <http://ctro/data#hasChangeValue> \"6 . 0\"."
67, mmHg, 1879, 1883, "mmHg", "", 
68, Bimatoprost, 1901, 1904, "BIM", "", 
60, ResultMeasuredValue, 1907, 1913, "17 . 2", "", "<http://ctro/data#Outcome_94994> <http://ctro/data#hasResultMeasuredValue> \"17 . 2\"."
62, SdDevResValue, 1916, 1921, "2 . 6", "", "<http://ctro/data#Outcome_94994> <http://ctro/data#hasSdDevResValue> \"2 . 6\"."
69, mmHg, 1922, 1926, "mmHg", "", 
66, Reduction, 1954, 1959, "6 . 3", "", "<http://ctro/data#Outcome_94994> <http://ctro/data#hasChangeValue> \"6 . 3\"."
64, mmHg, 1960, 1964, "mmHg", "", 
70, DiffGroupAbsValue, 2004, 2010, "0 . 22", "", "<http://ctro/data#DiffBetweenGroups_95021> <http://ctro/data#hasDiffGroupAbsValue> \"0 . 22\"."
71, mmHg, 2011, 2015, "mmHg", "", 
72, ConfIntervalDiff, 2018, 2046, "95 % CI , - 0 . 22 to 0 . 67", "", "<http://ctro/data#DiffBetweenGroups_95021> <http://ctro/data#hasConfIntervalDiff> \"95 % CI , - 0 . 22 to 0 . 67\"."
73, Travoprost, 2076, 2080, "TRAV", "", 
74, Bimatoprost, 2088, 2091, "BIM", "", 
75, Mean, 2111, 2115, "Mean", "", 
76, IOP, 2116, 2119, "IOP", "", 
77, Mean, 2143, 2147, "mean", "", 
78, IOP, 2163, 2166, "IOP", "", 
104747, EndPointDescription, 2324, 2345, "mild ocular hyperemia", "", "<http://ctro/data#EndPointDescription_95031> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_95030> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_95031>."
199, ConjunctivalHyperemia, 2329, 2345, "ocular hyperemia", "", 
82, Travoprost, 2351, 2355, "TRAV", "", 
83, Bimatoprost, 2360, 2363, "BIM", "", 
84, PercentageAffected, 2369, 2371, "31", "", "<http://ctro/data#Outcome_95040> <http://ctro/data#hasPercentageAffected> \"31\"."
85, PercentageAffected, 2378, 2380, "39", "", "<http://ctro/data#Outcome_95067> <http://ctro/data#hasPercentageAffected> \"39\"."
104749, EndPointDescription, 2400, 2418, "moderate hyperemia", "", "<http://ctro/data#EndPointDescription_95036> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_95035> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_95036>."
200, ConjunctivalHyperemia, 2409, 2418, "hyperemia", "", 
86, PercentageAffected, 2435, 2436, "2", "", "<http://ctro/data#Outcome_95094> <http://ctro/data#hasPercentageAffected> \"2\"."
88, Bimatoprost, 2461, 2464, "BIM", "", 
97, ConclusionComment, 2480, 2627, "Late - day IOP - lowering efficacy of BAK - free TRAV was noninferior to that of BAK 0 . 02 % - preserved BIM ; both reduced baseline IOP by 25 % .", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasConclusionComment> \"Late - day IOP - lowering efficacy of BAK - free TRAV was noninferior to that of BAK 0 . 02 % - preserved BIM ; both reduced baseline IOP by 25 % .\"."
90, IOP, 2491, 2494, "IOP", "", 
91, Travoprost, 2518, 2533, "BAK - free TRAV", "", 
204, Bimatoprost, 2561, 2564, "BAK", "", 
203, DoseValue, 2565, 2571, "0 . 02", "", 
204, Bimatoprost, 2574, 2589, "- preserved BIM", "", 
93, IOP, 2614, 2617, "IOP", "", 
94, RelativeReduction, 2621, 2623, "25", "", 
98, ConclusionComment, 2628, 2746, "Both treatments were well tolerated , although a higher incidence of moderate ocular hyperemia was observed with BIM .", "", "<http://ctro/data#ClinicalTrial_94888> <http://ctro/data#hasConclusionComment> \"Both treatments were well tolerated , although a higher incidence of moderate ocular hyperemia was observed with BIM .\"."
104750, EndPointDescription, 2697, 2722, "moderate ocular hyperemia", "", 
208, ConjunctivalHyperemia, 2706, 2722, "ocular hyperemia", "", 
95, Bimatoprost, 2741, 2744, "BIM", "", 
99, PMID, 2914, 2922, "25432143", "", "<http://ctro/data#Publication_94880> <http://ctro/data#hasPMID> \"25432143\"."
